Transient trimethylaminuria related to menstruation

<p>Abstract</p> <p>Background</p> <p>Trimethylaminuria, or fish odor syndrome, includes a transient or mild malodor caused by an excessive amount of malodorous trimethylamine as a result of body secretions. Herein, we describe data to support the proposal that menses ca...

Full description

Saved in:
Bibliographic Details
Main Authors: Yamazaki Hiroshi (Author), Cashman John R (Author), Shimizu Makiko (Author)
Format: Book
Published: BMC, 2007-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d90b49fad0dd4a0c9b85fd1b5bfcd4ad
042 |a dc 
100 1 0 |a Yamazaki Hiroshi  |e author 
700 1 0 |a Cashman John R  |e author 
700 1 0 |a Shimizu Makiko  |e author 
245 0 0 |a Transient trimethylaminuria related to menstruation 
260 |b BMC,   |c 2007-01-01T00:00:00Z. 
500 |a 10.1186/1471-2350-8-2 
500 |a 1471-2350 
520 |a <p>Abstract</p> <p>Background</p> <p>Trimethylaminuria, or fish odor syndrome, includes a transient or mild malodor caused by an excessive amount of malodorous trimethylamine as a result of body secretions. Herein, we describe data to support the proposal that menses can be an additional factor causing transient trimethylaminuria in self-reported subjects suffering from malodor and even in healthy women harboring functionally active flavin-containing monooxygenase 3 (FMO3).</p> <p>Methods</p> <p>FMO3 metabolic capacity (conversion of trimethylamine to trimethylamine <it>N</it>-oxide) was defined as the urinary ratio of trimethylamine <it>N</it>-oxide to total trimethylamine.</p> <p>Results</p> <p>Self-reported Case (A) that was homozygous for inactive Arg500stop FMO3, showed decreased metabolic capacity of FMO3 (i.e., ~10% the unaffected metabolic capacity) during 120 days of observation. For Case (B) that was homozygous for common [Glu158Lys; Glu308Gly] <it>FMO3 </it>polymorphisms, metabolic capacity of FMO3 was almost ~90%, except for a few days surrounding menstruation showing < 40% metabolic capacity. In comparison, three healthy control subjects that harbored heterozygous polymorphisms for [Glu158Lys; Glu308Gly] <it>FMO3 </it>or homozygous for wild <it>FMO3 </it>showed normal (> 90%) metabolic capacity, however, on days around menstruation the FMO3 metabolic capacity was decreased to ~60-70%.</p> <p>Conclusion</p> <p>Together, these results indicate that abnormal FMO3 capacity is caused by menstruation particularly in the presence, in homozygous form, of mild genetic variants such as [Glu158Lys; Glu308Gly] that cause a reduced FMO3 function.</p> 
546 |a EN 
690 |a Internal medicine 
690 |a RC31-1245 
690 |a Genetics 
690 |a QH426-470 
655 7 |a article  |2 local 
786 0 |n BMC Medical Genetics, Vol 8, Iss 1, p 2 (2007) 
787 0 |n http://www.biomedcentral.com/1471-2350/8/2 
787 0 |n https://doaj.org/toc/1471-2350 
856 4 1 |u https://doaj.org/article/d90b49fad0dd4a0c9b85fd1b5bfcd4ad  |z Connect to this object online.